Cytena GmbH, headquartered in Germany, is a pioneering company in the life sciences industry, specialising in single-cell dispensing technology. Founded in 2014, Cytena has rapidly established itself as a leader in the field, focusing on innovative solutions for biopharmaceutical research and development. The company’s flagship products, including the cytena C1 and the cytena C1-Cell, offer unique capabilities for isolating and analysing single cells, enabling researchers to enhance their workflows and improve data accuracy. With a commitment to quality and precision, Cytena has achieved significant milestones, including partnerships with major research institutions and a growing presence in key global markets. Recognised for its cutting-edge technology and contributions to the advancement of personalised medicine, Cytena GmbH continues to drive innovation in the life sciences sector, positioning itself as a trusted partner for researchers worldwide.
How does cytena GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
cytena GmbH's score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, cytena GmbH does not report specific carbon emissions figures, indicating a lack of detailed emissions data for the most recent year. However, the company is a current subsidiary of BICO Group AB (publ), which may influence its climate commitments and emissions reporting. While cytena GmbH has not set specific reduction targets or initiatives, it is important to note that its parent company, BICO Group AB (publ), may have established science-based targets (SBTi) and other climate-related commitments that could cascade down to cytena GmbH. This relationship suggests that cytena GmbH is likely aligned with broader sustainability goals set by BICO Group AB (publ), although specific details on these initiatives are not provided. In summary, cytena GmbH currently lacks specific emissions data and reduction targets, but its affiliation with BICO Group AB (publ) may imply adherence to industry-standard climate commitments and practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | 2,179,000 | 0,000,000 |
cytena GmbH's Scope 3 emissions, which increased by 99% last year and increased by approximately 99% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Business Travel" being the largest emissions source at 79% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
cytena GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.